Adlai Nortye

Adlai Nortye

Adlai Nortye engages in research and development of biopharmaceuticals for cancer immunotherapy.

HQ location
Hangzhou, China
Launch date
Employees
Market cap
$62.4m
Enterprise value
$29m
Share price
$1.68 ANL
Authorizing premium user...